Fas-induced expression of chemokines in human glioma cells: Involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase

Cancer Research

Volumn 61, Issue 7, 2001, Pages 3084-3091

  Choi, C ^a   Xu, X ^a   Oh, J W ^a   Sung Joong Lee, ^a   Gillespie, G Y ^a   Park, H ^a   Jo, H ^a   Benveniste, E N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

NON-PROGRAMMATIC;

ADULT; ANTIGENS, CD95; APOPTOSIS; CHEMOKINES; GLIOBLASTOMA; GLIOMA; HUMANS; INTERLEUKIN-8; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR CELLS, CULTURED;

EID: 0035300493     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Tumor necrosis factor receptor and Fas signaling mechanisms
2. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
3. The role of FasL-induced apoptosis in immune privilege
4. The Fas counterattack: Cancer as a site of immune privilege
5. Multiple sclerosis: Fas signaling in oligodendrocyte cell death
6. Involvement of the CD95 (APO-I/Fas) receptor/ligand system in multiple sclerosis brain
7. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis
8. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis
9. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
10. FasL (CD95L, ApolL) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
11. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-I, IL-6, TNF-α, or IFN-γ
12. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: A key role in brain inflammation?
13. FAS expression on human fetal astrocytes without susceptibility to FAS-mediated cytotoxicity
14. The roles of Fas, Fas ligand, and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis
15. Development of inflammatory angiogenesis by local stimulation of Fas in vivo
16. Regulation of the proinflammatory effects of Fas ligand (CD95L)
17. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
18. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation
19. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen
20. Differential regulation and function of Fas expression on glial cells
21. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines
22. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
23. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors
24. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis
25. Fas (APO-1/CD95) signaling pathway is intact in radioresistant human glioma cells
26. Cytokine regulation of CC and CXC chemokine expression by human astrocytes
27. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6, and interleukin 8
28. Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBP isoforms
29. Oncostatin M regulation of interleukin-6 expression in astrocytes: Biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38
30. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity
31. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
32. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
33. A synthetic inhibitor of the mitogen-activated protein kinase cascade
34. Human astrocytomas co-expressing Fas and Fas ligand also produce TGF-β2 and Bcl-2
35. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines
36. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
37. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
38. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
39. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system
40. IL-8 expression in malignant melanoma: Implications in growth and metastasis
41. The chemokine system: Redundancy for robust outputs
42. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro
43. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma
44. Tumor cell responses to IFN-γ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
45. IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of anglogenesis
46. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
47. MAP kinase pathways
48. Activation of apoptosis signal-regulating kinase 1 (ASKI) by the adapter protein Daxx
49. Acidic sphingomyelinase (ASM) is necessary for Fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells
50. Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas
51. Fas-induced apoptosis is mediated by activation of a Ras and Rac protein-regulated signaling pathway
52. CD95-dependent T-cell killing by glioma cells expressing CD95 ligand: More on tumor immune escape, the CD95 counterattack, and the immune privilege of the brain